TickerGuard
Buy Day today: Neutral (57) Mixed market breadth · no major macro event
IOVA

Iovance Biotherapeutics Inc

Healthcare · Biotechnology

14.60$ +9.8% vs. previous close Closing price · As of: Oct 9, 2026

Statements

Balance Sheet

Iovance Biotherapeutics Inc (IOVA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 916 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IOVA
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
182 172 155 138 174 155 307 285 271 481 462 436 396 345 288 818 782 768 751 853 829 777 701 611 546 664 825 757 852 780 870 964 991 910 967 907 905 913 926 916
181 170 153 135 171 149 303 280 266 475 445 411 367 316 256 783 724 636 605 667 583 508 490 432 370 479 638 275 383 308 386 482 499 457 513 423 429 443 467 464
93 166 147 114 163 145 297 246 81 82 54 77 39 14 53 161 68 67 132 83 59 78 92 108 118 232 543 230 268 115 134 229 164 116 172 132 158 163 197 111
179 166 147 129 163 145 297 246 260 469 440 404 362 307 246 772 714 629 594 656 576 504 482 424 360 472 626 251 361 280 356 413 397 324 360 301 301 297 313 298
– – – – – – – – – – – – – – – – – – – – – – – – – 0.0 – 0.0 0.0 0.2 0.2 32 56 69 71 60 67 82 82 102
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – 0.0 – 9.7 9.2 10 18 28 39 52 66 50 52 52 58 56
1.8 2.4 2.8 2.6 2.6 2.5 2.2 2.7 2.6 2.7 3.5 16 20 8.5 14 19 39 59 73 133 88 101 103 101 169 178 110 113 – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – 236 224 229 294 295 307 282 285 296 285 279 269 264
3.2 5.0 5.5 8.9 8.5 9.9 15 14 17 15 27 39 41 46 45 59 70 112 103 108 130 156 149 138 152 164 158 179 178 196 190 196 218 200 199 209 203 215 204 179
3.2 5.0 5.5 8.9 8.5 9.9 15 14 17 14 22 34 35 39 40 55 64 55 55 61 65 89 77 64 79 91 87 89 91 110 83 94 118 122 123 129 126 138 129 107
– – – – – – – – – – 6.1 7.5 8.4 7.3 6.4 5.9 7.2 6.3 5.9 4.4 6.6 5.1 7.7 6.5 7.2 13 13 11 10 7.8 11 11 12 13 9.5 8.1 7.3 4.0 3.9 2.7
0.2 0.9 2.2 3.7 2.9 1.2 6.6 5.2 6.0 2.7 7.6 13 9.9 16 11 10 25 14 13 22 12 27 20 20 24 27 32 31 19 33 26 20 32 28 28 32 31 22 37 26
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – 4.4 – – – – – – – 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 – – – – – –
179 167 150 129 165 145 293 271 254 466 435 397 355 299 243 758 712 656 647 744 698 622 552 473 394 500 667 579 674 585 680 769 773 710 768 698 702 699 722 736
-141 -157 -178 -201 -223 -249 -276 -306 -340 -373 -410 -458 -507 -571 -640 -703 -762 -830 -906 -987 -1,073 -1,172 -1,264 -1,363 -1,463 -1,568 -1,676 -1,782 -1,896 -2,012 -2,125 -2,222 -2,306 -2,385 -2,501 -2,612 -2,704 -2,776 -2,855 -2,902
59 62 62 62 63 73 84 90 95 119 123 124 124 126 127 133 146 146 147 154 156 157 157 157 158 165 214 224 246 256 266 285 303 305 323 335 364 407 419 450

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?